Related Experiment Videos
Gene delivery to spinal motor neurons
Z Sahenk1, J Seharaseyon, J R Mendell
1Department of Neurology, College of Medicine, Ohio State University, Columbus.
Brain Research
|March 19, 1993
Summary
Researchers directly delivered gene constructs to spinal motor neurons using retrograde transport. This method enables gene therapy for motor neuron diseases like spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS).
Area of Science:
- Neuroscience
- Molecular Biology
- Gene Therapy
Background:
- Spinal motor neuron diseases pose significant therapeutic challenges.
- Effective gene delivery to motor neurons is crucial for developing treatments.
- Current methods for motor neuron gene delivery are limited.
Purpose of the Study:
- To demonstrate direct plasmid gene construct delivery into spinal motor neurons.
- To utilize retrograde axoplasmic transport for gene delivery.
- To establish a foundation for gene therapy in motor neuron disorders.
Main Methods:
- Direct injection of plasmid vectors containing the Lac Z gene into the sciatic nerve or gastrocnemius muscle.
- Utilizing Rous sarcoma virus (RSV) and Simian virus (SV)40 promoters for gene expression.
- Histochemical staining and polymerase chain reaction (PCR) for detecting gene expression and construct presence.
Main Results:
- Successful delivery and expression of the Lac Z gene in alpha and gamma motor neurons.
- Confirmation of plasmid construct presence using PCR.
- Demonstration of functional retrograde axoplasmic transport for gene delivery.
Conclusions:
- Direct gene delivery to spinal motor neurons via retrograde transport is feasible.
- This technique offers a promising approach for studying gene regulation in motor neurons.
- The method holds potential for developing gene therapies for motor neuron diseases such as SMA and ALS.